Skip to main content
Log in

Evaluation of the treatment response of lung cancer with positron emission tomography and l-[methyl-11C]methionine: a preliminary study

  • Original Articles
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

We carried out a study to evaluate treatment response and residual mass in lung cancer with positron emission tomography (PET), using l-[methyl-11C]methionine (MET). MET tumour uptake and tumour volume measured by computed tomography (CT) before and within 2 weeks after radiotherapy or chemoradiotherapy were compared in 43 studies of 21 patients. Ten patients with local control (no recurrence) of tumour showed a larger decrease in MET uptake (65.2%±12.2%) than in tumour volume (50.8%±9.6%, P<0.01). Five patients with early recurrence (from 1 to 4 months) showed smaller decreases in both MET uptake (22.2%±13.5%) and tumour volume (28.6%±20.0%) than those in the no-recurrence group (P<0.01). Four patients with late recurrence (after 11 months or more) showed a similar decrease to the no-recurrence group in MET uptake (72.8%±14.8%) but little change in tumour volume (18.5%±19.0%), the latter result corresponding to that in the early-recurrence group. Using tumour volume only, the no-recurrence group was differentiated from both the early- and the late-recurrence group (P < 0.01), but the early-recurrence group was not differentiated from the late-recurrence group. Using the MET uptake data, the early-recurrence group was clearly distinguished from the late-recurrence group (P<0.01), but the late-recurrence group was indistinguishable from the no-recurrence group. CT was useful in distinguishing the no-recurrence group from the groups in which there was ultimate recurrence, whether early or late. When a residual mass is seen on CT, PET seems to be helpful in evaluating tumour viability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Steel GG. Cell population kinetics of tumours in experimental animals. In: Steel GG, ed. Growth kinetics of tumours. Oxford: Clarendon Press; 1977:146–184

    Google Scholar 

  2. Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med 1988;29:1521–1525

    Google Scholar 

  3. Minn H, Soini I. 18F fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer. Eur J Nucl Med 1989;15:61–66

    Google Scholar 

  4. Abe Y, Matsuzawa T, Fujiwara T, et al. Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-doexy-d-glucose and positron emission tomography: preliminary study of lung cancer. Int J Radiat Oncol Biol Phys 1990;19:1005–1010

    Google Scholar 

  5. Nagata Y, Yamamoto K, Hiraoka M, et al. Monitoring liver tumor therapy with [18F]FDG positron emission tomography. J Comput Assist Tomogr 1990;14:370–374

    Google Scholar 

  6. Okazumi S, Isono K, Enomoto K, et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J Nucl Med 1992;33:333–339

    Google Scholar 

  7. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991;32:1485–1490

    CAS  PubMed  Google Scholar 

  8. Engenhart R, Kimming BN, Strauss LG, et al. Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. Strahlenther Onkol 1992;168:203–212

    Google Scholar 

  9. Ichiya Y, Kuwabara Y, Otsuka M, et al. Assessment of response to cancer therapy using fluorine-l8-fluorodeoxyglucose and positron emission tomography. J Nucl Med 1991;32:1655–1660

    Google Scholar 

  10. Bergström M, Muhr C, Lundberg PO, et al. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study. J Comput Assist Tomogr 1987;11:815–819

    Google Scholar 

  11. Derlon JM, Bourdet C, Bustany P, et al. [11C]l-methionine uptake in gliomas. Neurosurgery 1989;25:720–728

    CAS  PubMed  Google Scholar 

  12. Leskinen-Kallio S, Minn H, Joensuu H. PET and [11C]methionine in assessment of response in non-Hodgkin lymphoma. Lancet 1990;336:1188

    Google Scholar 

  13. Kubota K, Yamada S, Ishiwata K, et al. Positron emission tomography for treatment evaluation and recurrence detection compared to CT in long follow-up case of lung cancer. Clin Nucl Med 1992;17:877–881

    Google Scholar 

  14. Mountain CF. The new international staging system for lung cancer. Surg Clin North Am 1987;67:925–935

    Google Scholar 

  15. Ishiwata K, Ido T, Abe Y. Tumor uptake studies of S-adenosyl-l-[methyl-11C]methionine and l-[methyl-11C]methionine. Int J Rad Appl Instrum [B] 1988;15:123–126

    Google Scholar 

  16. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990;31:1927–1933

    Google Scholar 

  17. Ishiwata K, Vaalburg W, Elsinga PH. Comparison of l-[1-11C]methionine and l-methyl-[11C]methionine for measuring in vivo protein synthesis rates with PET. J Nucl Med 1988; 29:1419–1427

    Google Scholar 

  18. Ullrich RL, Casarett GW. Interrelationship between the early inflammatory response and subsequent fibrosis after radiation exposure. Radiat Res 1977;72:107–121

    Google Scholar 

  19. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972–1980

    CAS  PubMed  Google Scholar 

  20. Kubota K, Ishiwata K, Kubota R, et al. Tracer feasibility for monitoring of tumor radiotherapy: quadruple-tracer study with fluorine-l8-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, l-methyl-14C methionine, 6-3H thymidine, and gallium-67. J Nucl Med 1991;32:2118–2123

    CAS  PubMed  Google Scholar 

  21. Kubota K, Matsuzawa T, Takahashi T, et al. Rapid and sensitive response of carbon-11-l-methionine tumor uptake to irradiation. J Nucl Med 1989;30:2012–2016

    Google Scholar 

  22. Kubota K, Ishiwata K, Yamada S, et al. Dose-responsive effect of radiotherapy on the tumor uptake of l-[methyl-11C]methionine; feasibility for monitoring recurrence of tumor. Int J Rad Appl Instrum [B] 1992;19:123–126

    Google Scholar 

  23. Hall EJ. Time, dose, and fractionation in radiotherapy. In: Hall EJ, ed. Radiobiology for the radiologist, 3rd edn. Philadelphia: Lippincott; 1988:240–259

    Google Scholar 

  24. Peters LJ, Brock WA, Chapman JD, et al. Predicitive assays of tumor radiocurability. Am J Clin Oncol 1988;11:275–287

    Google Scholar 

  25. Johnson DH, Einhorn LH, Bartolucci A, et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med 1990;113:33–38

    Google Scholar 

  26. Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the patterns of failure on patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer 1987;59:1874–1881

    Google Scholar 

  27. Leskinen-Kallio S, Någren K, Lehikoinen P, et al. Uptake of 11C-methionine in breast cancer studied by PET. An association with the size of S-phase fraction. Br J Cancer 1991; 64:1121–1124

    CAS  PubMed  Google Scholar 

  28. Leskinen-Kallio S, Ruotsalainen U, Nagren K, et al. Uptake of carbon- 11-methionine and fluorodoxyglucose in non-Hodgkin's lymphoma: a PET study. J Nucl Med 1991;32:1211–1218

    Google Scholar 

  29. Leskinen-Kallio S, Någren K, Lehikoinen P, et al. Carbon-11-methionine and PET is an effective method to image head and neck cancer. J Nucl Med 1992;33:691–695

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to: K. Kubota

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kubota, K., Yamada, S., Ishiwata, K. et al. Evaluation of the treatment response of lung cancer with positron emission tomography and l-[methyl-11C]methionine: a preliminary study. Eur J Nucl Med 20, 495–501 (1993). https://doi.org/10.1007/BF00175162

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00175162

Key words

Navigation